Adult Medicine PRN Focus Session — Outpatient to Inpatient and Back Again: Transitions of Care Challenges in Anticoagulation, Diabetes, and Pain Management
Sunday, October 13, 2024 from 2:15 PM to 3:45 PM MST
Available for 1.50 hours of CPE credit
Activity Number: 0217-0000-24-114-L01-P
Activity Type: An Application-Based Activity
This educational session will focus on transitions of care challenges for the general medicine practitioner. Specific topics will include 1) Inpatient to outpatient anticoagulation concerns, including access, monitoring, and overlap of medications; 2) Changes in inpatient to outpatient diabetes management, including the role of oral antihyperglycemic medications in the inpatient setting, steroid induced hyperglycemia, and the inpatient use of outpatient diabetes technologies; and 3) Challenges and changes in the management of pain and opioid use disorder, including the impact of DEA X and DATA 2000 waiver changes and the expanded inpatient management of opioid use disorder. The purpose of this session is to update adult medicine practitioners on current best practices in transitions of care pertaining to select high-risk medication classes and disease states including diabetes, anticoagulation, and pain that may impact patients in the non-ICU inpatient and outpatient settings.
Faculty
 | | Moderator: | Jordan A. (Perrine) Fuller, Pharm.D., MBA, BCCCP, BCPS |
|
Learning Objectives
1. Analyze the impact of anticoagulation transitions in various healthcare settings, such as ambulatory oral anticoagulant use and subsequent inpatient transitions.
2. Formulate a plan to overcome barriers to transitions of care for patients on anticoagulation.
3. Examine common diabetes-related transition of care topics, including changes in inpatient to outpatient diabetes management, and steroid induced hyperglycemia.
4. Examine the inpatient use of outpatient diabetes technologies and implement strategies to minimize or prevent medication and/or technology errors that commonly occur in transitions of care for patients with diabetes.
5. Review legislative changes to opioid use disorder treatment, including DATA 2000 and elimination of requirements.
6. Design a treatment plan for opioid withdrawal and pain management in patients with opioid use disorder, with emphasis on how this affects transitions of care.
Transitions of Care in Anticoagulation2:15 PM to 2:45 PM |
Transitions of Care in Diabetes2:45 PM to 3:15 PM  | | Speaker: | Jennifer N. Clements, Pharm.D., FCCP, BCACP, BCPS | | Clinical Pharmacist in Diabetes Transition, Spartanburg Regional Healthcare System, Spartanburg, South Carolina | | View Biography |
|
|
Transitions of Care in Pain and Opioid Use3:15 PM to 3:45 PM  | | Speaker: | Lyndsi K. Meyenburg, Pharm.D., BCPS |
|
|